Some patients experience a treatment journey that’s anything but a straight line
If you’ve been struggling with a lack of response or unmanageable side effects from your current medication for Ph+ CML in chronic phase, you’re not alone. Some patients have had to deal with the same issues—as you’ll see from the videos below.
Al’s Journey
Al was diagnosed with Ph+ CML in chronic phase in 1997. Back then, there were no tyrosine kinase inhibitors (TKIs) approved for treatment of the disease. Over time, that changed and Al’s story follows the gains that have been made in treatment over the last 2 decades. Learn how Al’s journey took him from one medication to the next until his doctor of more than 20 years suggested that he participate in the clinical trials for SCEMBLIX.
Lynne’s Journey
Diagnosed in 2005, Lynne tried several medications for Ph+ CML in chronic phase over the years. With each medication came more side effects than Lynne would care to mention. A big believer in advocating for herself, Lynne discussed her side effects openly with her doctors. After struggling with other medications, Lynne participated in the clinical trials for SCEMBLIX. That was back in 2015 and Lynne has been seeing results with SCEMBLIX ever since.
